ANTARES PHARMA INC's ticker is ATRS and the CUSIP is 036642106. A total of 128 filers reported holding ANTARES PHARMA INC in Q2 2019. The put-call ratio across all filers is 1.47 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $1,184,000 | -19.1% | 288,794 | -29.6% | 0.00% | – |
| Q4 2021 | $1,464,000 | +92.4% | 410,472 | +96.5% | 0.00% | – |
| Q3 2021 | $761,000 | -52.8% | 208,878 | -43.5% | 0.00% | – |
| Q2 2021 | $1,612,000 | +18.0% | 369,833 | +11.3% | 0.00% | – |
| Q1 2021 | $1,366,000 | -45.5% | 332,414 | -47.1% | 0.00% | – |
| Q4 2020 | $2,506,000 | +228.9% | 628,080 | +122.7% | 0.00% | – |
| Q3 2020 | $762,000 | +70.9% | 282,024 | +73.8% | 0.00% | – |
| Q2 2020 | $446,000 | -17.7% | 162,227 | -29.4% | 0.00% | – |
| Q1 2020 | $542,000 | -64.7% | 229,866 | -29.6% | 0.00% | – |
| Q4 2019 | $1,534,000 | -19.2% | 326,334 | -42.5% | 0.00% | – |
| Q3 2019 | $1,899,000 | -71.7% | 567,759 | -72.1% | 0.00% | – |
| Q2 2019 | $6,705,000 | +187.5% | 2,037,599 | +164.7% | 0.00% | -100.0% |
| Q1 2019 | $2,332,000 | +76.8% | 769,746 | +58.7% | 0.00% | – |
| Q4 2018 | $1,319,000 | -31.6% | 484,958 | -15.5% | 0.00% | -100.0% |
| Q3 2018 | $1,929,000 | +332.5% | 573,894 | +232.4% | 0.00% | – |
| Q2 2018 | $446,000 | +316.8% | 172,668 | +256.0% | 0.00% | – |
| Q1 2018 | $107,000 | -69.6% | 48,500 | -72.6% | 0.00% | – |
| Q4 2017 | $352,000 | +67.6% | 176,983 | +173.5% | 0.00% | – |
| Q3 2017 | $210,000 | +4.5% | 64,700 | +3.4% | 0.00% | – |
| Q2 2017 | $201,000 | -90.5% | 62,600 | -91.6% | 0.00% | -100.0% |
| Q1 2017 | $2,113,000 | +631.1% | 744,050 | +499.7% | 0.00% | – |
| Q4 2016 | $289,000 | +122.3% | 124,061 | +60.1% | 0.00% | – |
| Q3 2016 | $130,000 | -50.9% | 77,479 | -69.3% | 0.00% | – |
| Q2 2016 | $265,000 | +919.2% | 252,528 | +723.7% | 0.00% | – |
| Q1 2016 | $26,000 | -78.7% | 30,657 | -69.6% | 0.00% | – |
| Q4 2015 | $122,000 | -27.8% | 100,722 | +1.3% | 0.00% | – |
| Q3 2015 | $169,000 | -34.0% | 99,471 | -19.2% | 0.00% | – |
| Q2 2015 | $256,000 | -57.0% | 123,037 | -44.0% | 0.00% | – |
| Q1 2015 | $596,000 | -4.0% | 219,749 | -9.0% | 0.00% | – |
| Q4 2014 | $621,000 | -8.4% | 241,424 | -34.8% | 0.00% | – |
| Q3 2014 | $678,000 | -43.3% | 370,298 | -17.4% | 0.00% | – |
| Q2 2014 | $1,196,000 | -43.0% | 448,132 | -25.3% | 0.00% | – |
| Q1 2014 | $2,099,000 | -14.5% | 599,732 | +9.5% | 0.00% | -100.0% |
| Q4 2013 | $2,454,000 | -0.3% | 547,933 | -9.6% | 0.00% | 0.0% |
| Q3 2013 | $2,462,000 | +154.1% | 606,312 | +160.3% | 0.00% | – |
| Q2 2013 | $969,000 | – | 232,901 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sargent Investment Group, LLC | 4,598,329 | $10,852,000 | 4.99% |
| Soleus Capital Management, L.P. | 864,100 | $2,039,000 | 2.37% |
| Healthcare Value Capital, LLC | 500,000 | $1,180,000 | 1.98% |
| ORACLE INVESTMENT MANAGEMENT INC | 1,227,114 | $2,896,000 | 0.86% |
| PERKINS CAPITAL MANAGEMENT INC | 232,166 | $548,000 | 0.66% |
| Stonepine Capital Management, LLC | 151,189 | $357,000 | 0.38% |
| Zebra Capital Management LLC | 84,963 | $200,000 | 0.32% |
| Intrinsic Edge Capital Management LLC | 1,000,000 | $2,360,000 | 0.31% |
| Alambic Investment Management, L.P. | 46,069 | $109,000 | 0.26% |
| OBERWEIS ASSET MANAGEMENT INC/ | 200,600 | $473,000 | 0.26% |